Two-year results indicate spectacle lens slows myopia by 67%

Findings on the effectiveness of the Essilor Stellest lens will be presented at ARVO in May

child drawing
New results illustrating the effectiveness of the Essilor Stellest lens in slowing the progression of myopia will be presented at the annual meeting of the Association for Research in Vision and Ophthalmology in May.

Clinical trial results indicate that after two years wearing the lenses for 12 hours or more each day, the progression of myopia slowed down by 67% on average when compared to children wearing single vision lenses.

The study results indicated that two in three children who wore Essilor Stellest lenses did not need a prescription change after one year.

After one year, the eye growth of 90% of children wearing Essilor Stellest lenses was similar or slower than that of non-myopic children.

The results will be presented by Jinhua Bao, associate professor at Wenzhou Medical College, China on 6 May in a paper titled Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomised clinical trial.